Lee Anne McLean

896 total citations
12 papers, 740 citations indexed

About

Lee Anne McLean is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lee Anne McLean has authored 12 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lee Anne McLean's work include HER2/EGFR in Cancer Research (3 papers), Ion Transport and Channel Regulation (3 papers) and Advanced Breast Cancer Therapies (2 papers). Lee Anne McLean is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Ion Transport and Channel Regulation (3 papers) and Advanced Breast Cancer Therapies (2 papers). Lee Anne McLean collaborates with scholars based in United States, Switzerland and Spain. Lee Anne McLean's co-authors include Peter M. Cala, Fredric A. Gorin, Nanna K. Jørgensen, Dale Benos, Catherine M. Fuller, G. Yancey Gillespie, James M. Markert, Timothy B. Mapstone, James K. Bubien and Steven R. Gullans and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lee Anne McLean

12 papers receiving 726 citations

Peers

Countries citing papers authored by Lee Anne McLean

Since Specialization

Citations

This map shows the geographic impact of Lee Anne McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Anne McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Anne McLean more than expected).

Fields of papers citing papers by Lee Anne McLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Anne McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Anne McLean. The network helps show where Lee Anne McLean may publish in the future.

Co-authorship network of co-authors of Lee Anne McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Anne McLean. A scholar is included among the top collaborators of Lee Anne McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Anne McLean. Lee Anne McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Abstract OT1-02-03: Trastuzumab deruxtecan (T-DXd; DS-8201) vs trastuzumab emtansine (T-DM1) in high-risk patients with HER2-positive, residual invasive early breast cancer after neoadjuvant therapy: A randomized, phase 3 trial (DESTINY-Breast05) 2022 ·Cancer Research ·Charles E. Geyer, Michael Untch, Aleix Prat, Priya Rastogi, Naoki Niikura, (unknown), Lee Anne McLean, Yibin Wang, Sibylle Loibl	7
2	Abstract OT-03-01: Trastuzumab deruxtecan (T-DXd; DS-8201) vs trastuzumab emtansine (T-DM1) in high-risk patients with HER2-positive, residual invasive early breast cancer after neoadjuvant therapy: A randomized, phase 3 trial (DESTINY-Breast05) 2021 ·Cancer Research ·Charles E. Geyer, Michael Untch, Aleix Prat, Priya Rastogi, Naoki Niikura, (unknown), Lee Anne McLean, Yibin Wang, Sibylle Loibl	10
3	KEYNOTE-590: Phase III Study of First-Line Chemotherapy with or Without Pembrolizumab for Advanced Esophageal Cancer 2019 ·Future Oncology ·Ken Kato, Manish A. Shah, Peter C. Enzinger, Jaafar Bennouna, Lin Shen, Antoine Adenis, Jong‐Mu Sun, Byoung Chul Cho, Mustafa Özgüroğlu, Takashi Kojima, Vladimir Kostorov, Cinta Hierro, Ying Zhu, Lee Anne McLean, Sukrut Shah, Toshihiko Doi	125
4	116TiP MONALEESA-7: a phase III, randomized, double-blind, placebo-controlled study of ribociclib (LEE011) combined with standard first-line endocrine therapy (ET) for the treatment of premenopausal women with HR +, HER2– advanced breast cancer (aBC) 2015 ·Annals of Oncology ·Seock‐Ah Im, Louis WC Chow, Zhi‐Ming Shao, Debu Tripathy, Aditya Bardia, SA Hurvitz, Nadia Harbeck, Marco Colleoni, (unknown), Caroline Germa, Gareth Hughes, Lee Anne McLean, (unknown), (unknown)	1
5	Aliskiren toxicity in juvenile rats is determined by ontogenic regulation of intestinal P-glycoprotein expression 2014 ·Toxicology and Applied Pharmacology ·Peter Hoffmann, David A. Beckman, Lee Anne McLean, (unknown)	8
6	The Use of Rat Lens Explant Cultures to Study the Mechanism of Drug-Induced Cataractogenesis 2011 ·Toxicological Sciences ·(unknown), Lee Anne McLean, Chiara Buono, Pierre Moulin, Armin Wolf, Salah‐Dine Chibout, François Pognan, Steve Busch, Nandita Shangari, Elba de la Cruz, Maya Gurnani, Parul Patel, Albert Reising	6
7	Correlation of Major Cytogenetic Response with a Pharmacogenetic Marker in Chronic Myeloid Leukemia Patients Treated with Imatinib (STI571) 2004 ·Clinical Cancer Research ·Marlene Dressman, (unknown), Lee Anne McLean, Insa Gathmann, Renaud Capdeville, Martee L. Hensley, Mihael H. Polymeropoulos, (unknown)	21
8	Pharmacogenomic Analysis of Cytogenetic Response in Chronic Myeloid Leukemia Patients Treated with Imatinib 2004 ·Clinical Cancer Research ·Lee Anne McLean, Insa Gathmann, Renaud Capdeville, Mihael H. Polymeropoulos, Marlene Dressman	62
9	Acid-sensing Ion Channels in Malignant Gliomas 2003 ·Journal of Biological Chemistry ·Bakhrom K. Berdiev, Jiazeng Xia, Lee Anne McLean, James M. Markert, G. Yancey Gillespie, Timothy B. Mapstone, Anjaparavanda P. Naren, Biljana Jovov, James K. Bubien, Hong-Long Ji, Catherine M. Fuller, Kevin L. Kirk, Dale Benos	121
10	Differential gene expression profiling in human brain tumors 2001 ·Physiological Genomics ·James M. Markert, Catherine M. Fuller, G. Yancey Gillespie, James K. Bubien, Lee Anne McLean, Robert L. Hong, (unknown), Steven R. Gullans, Timothy B. Mapstone, Dale Benos	191
11	Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes 2000 ·American Journal of Physiology-Cell Physiology ·Lee Anne McLean, (unknown), Nanna K. Jørgensen, Fredric A. Gorin, Peter M. Cala	158
12	Cloning and expression of the Na⁺/H⁺exchanger fromAmphiumaRBCs: resemblance to mammalian NHE1 1999 ·American Journal of Physiology-Cell Physiology ·Lee Anne McLean, Shaheen Zia, Fredric A. Gorin, Peter M. Cala	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact